Comparison of a Vasoconstrictor and a Vasodilator in Pharmacoangiography of Bone and Soft-Tissue Tumors

Authors:
  • LELeif Ekelund
    Leif Ekelund
  • SLSven Laurin
    Sven Laurin
  • ALAnders Lunderquist
    Anders Lunderquist

Abstract
The pharmacoangiographic effect of a vasoconstrictor (angiotensin) and a vasodilator (tolazoline) was compared in 18 patients with bone and soft tissue tumors. Angiotensin was the drug of choice in increasing diagnostic information in angiography. Ten to 15 .mu.g of angiotensin seems to be a convenient dose in the axillary, iliac and femoral arteries.